Irreplaceable partners in solutions


Almost 2 million people die every year from tuberculosis and hundreds of millions are affected directly through this infectious disease and/or its damaging impact on children, families, communities and health, economic and social conditions.

TBVI's global approach in resolving this major health issue includes engagement of the most renowned European researchers, experts and tools to mobilize the best knowledge and much needed resources. Cooperation is part of our strategy, our working model and our projects.

Foundations are irreplaceable partners in our solutions. Because of their resources, knowledge, expertise in health, poverty and research related issues and the power to raise awareness. Foundations looking for innovative projects, can be involved in our inventive solutions. Please contact us for more information.

TBVI commits to responsible use of all resources, effective solutions and long term positive social and economic impact.

What do we offer our partners?

  • Access to our research results
  • Possibilities for participation in Board of Trustees of TBVI, our prestigious network of globally renowned scientists, academic and political experts in health
  • Working together on development of tools against elimination of TB
  • Participation in our innovative way of funding, combining investment and charity
  • Possibilities for tax incentives
  • Cross sector cooperation – foundations, governments and private industries in a strong partnership to eliminate a major global health issue
  • Pan-European approach – joint expertise of almost 40 worldwide research expert institutions

Social Impact

  • With new vaccines save around 2 million lives a year and prevent suffering for millions of people
  • Bring concrete solutions - TBVI's track record already shows high probability of success. Vaccines generally proved as promising and cost efficient
  • Reduce poverty and stigmatization of people affected by tuberculosis
  • Relieve communities affected by tuberculosis from the social and economic burdens caused by the disease
  • Long term impact
  • Healthy communities for people and businesses

Economic impact

  • New vaccines will save hundreds of billions euro to the world economy, as the economic loss caused by tuberculosis now amounts to 0,52 per cent of the world’s gross national income
  • Contribution to Europe's new knowledge based economy and technology
  • Direct benefits to society: economic and social return on investment
  • Cost efficiency: no investment wasted
  • Knowledge and experience that is transferable worldwide 
  • Leverage – elimination of tuberculosis will economically benefit families, communities, governments and companies.

Contact

René Coppens MSc
Director Resource Mobilisation
+31 6 83444183
rene.coppens(at)tbvi.eu

 

Investing in TB vaccines is a good cause, with potentially huge returns on investment. Not only in dollars, but also in lives saved.

Jan Gheuens, senior programme officer, Bill & Melinda Gates Foundation